Get started
Award

R01 DK054163

Funded outputs count: 36
Funder award ID: R01 DK054163
OpenAlex ID: G4075530747
N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and Testosterone
2009 · Shalender Bhasin, E. Jiaxiu He, et al. · The Journal of Clinical Endocrinology & Metabolism · 62
PDF
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial
2008 · Fred R Sattler, Natasa Rajicic, et al. · American Journal of Clinical Nutrition · 44
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2β)-Null Mice
2008 · Sasanka Ramanadham, Kevin E. Yarasheski, et al. · American Journal Of Pathology · 64
PDF
Post‐exercise heart rate recovery in HIV‐positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?
2007 · WT Cade, DN Reeds, et al. · HIV Medicine · 20
Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels
2007 · Pablo Tebas, Jiameng Zhang, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 59
Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates
2007 · Randall J. Bateman, Ling Y. Munsell, et al. · Journal of the American Society for Mass Spectrometry · 76
Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART
2006 · W. Todd Cade, Dominic N. Reeds, et al. · American Journal of Physiology-Endocrinology and Metabolism · 34
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance
2006 · Dominic N. Reeds, W. Todd Cade, et al. · Diabetes · 30
Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia
2005 · D. N. Reeds, K. E. Yarasheski, et al. · American Journal of Physiology-Endocrinology and Metabolism · 52
A Randomized, Placebo-Controlled Trial of Nandrolone Decanoate in Human Immunodeficiency Virus-Infected Men with Mild to Moderate Weight Loss with Recombinant Human Growth Hormone as Active Reference Treatment
2005 · Thomas W. Storer, Linda J. Woodhouse, et al. · The Journal of Clinical Endocrinology & Metabolism · 62
Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals
2005 · Gene D. Morse, Susan Rosenkranz, et al. · Antimicrobial Agents and Chemotherapy · 20
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy
2005 · Juan Chaparro, Dominic N. Reeds, et al. · Metabolism · 33
Alendronate, Vitamin D, and Calcium for the Treatment of Osteopenia/Osteoporosis Associated With HIV Infection
2005 · Kristin Mondy, William G Powderly, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 152
Reducing plasma HIV RNA improves muscle amino acid metabolism
2004 · Kevin E. Yarasheski, Samuel R. Smith, et al. · American Journal of Physiology-Endocrinology and Metabolism · 27
Niacin in HIV-Infected Individuals with Hyperlipidemia Receiving Potent Antiretroviral Therapy
2004 · M. T. Gerber, K. E. Mondy, et al. · Clinical Infectious Diseases · 64
Evaluation of the Virological and Metabolic Effects of Switching Protease Inhibitor Combination Antiretroviral Therapy to Nevirapine-Based Therapy for the Treatment of HIV Infection
2004 · Pablo Tebas, Kevin Yarasheski, et al. · AIDS Research and Human Retroviruses · 51
PDF
Review Article: Exercise, Aging, and Muscle Protein Metabolism
2003 · K. E. Yarasheski · The Journals of Gerontology Series A · 173
Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia
2003 · Kevin E. Yarasheski, Pablo Tebas, et al. · American Journal of Physiology-Endocrinology and Metabolism · 23
Alterations in lipid kinetics in men with HIV-dyslipidemia
2003 · D. N. Reeds, B. Mittendorfer, et al. · American Journal of Physiology-Endocrinology and Metabolism · 97
HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D
2003 · Mario Cozzolino, Marcos Vidal, et al. · AIDS · 220
Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus–Infected Individuals
2003 · Kristin Mondy, Kevin Yarasheski, et al. · Clinical Infectious Diseases · 305
Exercise treatment to counteract protein wasting of chronic diseases
2003 · Erin M. Zinna, Kevin E. Yarasheski · Current Opinion in Clinical Nutrition & Metabolic Care · 104
Exercise Treatment for HIV???Associated Metabolic and Anthropomorphic Complications
2001 · Kevin E. Yarasheski, Ronenn Roubenoff · Exercise and Sport Sciences Reviews · 37
The HIV Protease Inhibitor Indinavir Decreases Insulin- and Contraction-Stimulated Glucose Transport in Skeletal Muscle
2001 · Lorraine A. Nolte, Kevin E. Yarasheski, et al. · Diabetes · 92
PDF
Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy
2001 · Kevin E. Yarasheski, Pablo Tebas, et al. · Journal of Applied Physiology · 136
Year
Topic